Three posters related to drug regulatory harmonization were recently selected as winners by the PANDRH Secretary. The posters were presented at the VII PANDRH Conference. Ottawa, Canada, 5 - 7 September, 2013.
The poster session at the VII PANDRH Conference aims to provide a place for presenting the state of art of different regulatory aspects of health technologies in the Americas region.
The poster topics of were subject to the scope of PANDRH, particularly:
• Good regulatory practices and regulatory science
• Experiences of inter?institutional and international technical cooperation
• Successful experiences in human resource training and/or development of national competencies
• Impact of the adoption of new regulatory guidelines from an institutional, academic or industrial perspective
The poster session at the VII CPANDRH aims to provide a place for presenting the state of the art of different regulatory
aspects of health technologies in the Americas region.
Each poster was presented only after an abstract approved by a committee of experts. The document Abstracts of the VII CPANDRH shows all approved abstracts to VII CPANDRH. During the last day of the conference an Evaluation Committee selected three posters for outstanding excellence. As part of the recognition, the authors of the three selected posters will each receive an Honorable Mention Certificate.
The winners posters are the following:
Author: Piñeiro Rodrigo, Luis
Institution: Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT)
Title: pdf Joint operations to combat illegal drugs: cooperation between Anvisa and Ministry of Justice / Operações conjuntas de combate a medicamentos ilegais: a cooperação Anvisa e Ministério da Justiça
Authors: Wzorek, Lorilei de Fátima; Chagas, Patricia Azevedo; Pontarolo, Roberto
Institution: Agência Nacional de Vigilância Sanitária (Anvisa), Universidade Federal do Paraná (UFPR)
Authors: Sarjeant, J.M.; Wang, J.; and Klein, Agnes V.
Institution: Medical Officer, Clinical Evaluation Division — Hematology/Oncology, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics (CERB), Biologics and Genetic Therapies Directorate (BGTD), Health Canada.
For more information read the document Abstracts of the VII CPANDRH